Natural health product-HIV drug interactions: a systematic review

被引:36
作者
Mills, E
Montori, V
Perri, D
Phillips, E
Koren, G
机构
[1] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[2] Mayo Clin, Coll Med, Dept Endocrinol, Rochester, MN USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Hosp Sick Children, Dept Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada
关键词
natural health products; complementary therapies; drug interactions; systematic review;
D O I
10.1258/0956462053420103
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The use of natural health products (NHPs) within the HIV community is high. Several NHPs have demonstrated interactions with HIV medications that could contribute to drug failure. We aimed to conduct a systematic review of clinical trials examining NHP-HIV drug interactions and their methodological characteristics. We searched electronic databases and unpublished resources independently, in duplicate. Nine studies were identified, eight clinical pharmacokinetics trials and one population-pharmacokinetics trial. Investigators studied four different herbal medicines (St John's wort, garlic, goldenseal and milk thistle) and one vitamin (vitamin Q. Significant interactions were observed with St John's wort, garlic and vitamin C. However, methodological challenges exist to making the results directly generalizable to patients. This review finds that important drug level changes exist when NHPs are combined with HIV medications. Considering patient values and the implications of these studies, further research is urgently required to determine the extent of interactions with other commonly used NHPs.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 24 条
  • [1] Altman D. G., 2000, Statistics with Confidence, P28
  • [2] Altman DG, 1999, BRIT MED J, V318, P1209
  • [3] Brazier Nicole C, 2003, Am J Ther, V10, P163, DOI 10.1097/00045391-200305000-00003
  • [4] Drug interaction between St John's wort and nevirapine
    de Maat, MMR
    Hoetelmans, RMW
    Mathôt, RAA
    van Gorp, ECM
    Meenhorst, PL
    Mulder, JW
    Beijnen, JH
    [J]. AIDS, 2001, 15 (03) : 420 - 421
  • [5] Coadministration of milk thistle and indinavir in healthy subjects
    DiCenzo, R
    Shelton, M
    Jordan, K
    Koval, C
    Forrest, A
    Reichman, R
    Morse, G
    [J]. PHARMACOTHERAPY, 2003, 23 (07): : 866 - 870
  • [6] Use of complementary and alternative therapies in HIV-infected patients
    Duggan, J
    Peterson, WS
    Schutz, M
    Khuder, S
    Charkraborty, J
    [J]. AIDS PATIENT CARE AND STDS, 2001, 15 (03) : 159 - 167
  • [7] Complementary medicine and HIV infection
    Elion, RA
    Cohen, C
    [J]. PRIMARY CARE, 1997, 24 (04): : 905 - +
  • [8] Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients
    Fairfield, KM
    Eisenberg, DM
    Davis, RB
    Libman, H
    Phillips, RS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (20) : 2257 - 2264
  • [9] Herb-drug interactions: Review and assessment of report reliability
    Fugh-Berman, A
    Ernst, E
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (05) : 587 - 595
  • [10] Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada
    Furler, MD
    Einarson, TR
    Walmsley, S
    Millson, M
    Bendayan, R
    [J]. AIDS PATIENT CARE AND STDS, 2003, 17 (04) : 155 - 168